Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Some chemotherapy can cause permanent hair loss.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Grape sap may help reduce hair loss and promote hair growth in rats.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.